Dr Moncef Slaoui, former pharma exec and chief Scientist for Trump’s “Operation Warp Speed,” which aims to develop a working Covid-19 vaccine as fast as possible, has more than $10 million in stock options in one of the companies receiving federal funding.
Described across four separate filings, Slaoui has 155,438 options in Moderna. The stake is worth $10,366,000 at Moderna’s current share price, $66.69 at the time of publication.